Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

A highly fluorescent and readily accessible all-organic photosensitizer model for advancing image-guided cancer PDT

  • Garcia Sampedro, Andrés
  • Prieto Castañeda, Alejandro
  • Rodríguez Agarrabeitia, Antonia
  • Bañuelos Prieto, Jorge
  • García Moreno, Inmaculada
  • Villanueva Oroquieta, Ángeles
  • Moya Cerero, Santiago de la
  • Ortiz García, María Josefa
  • Acedo Núñez, Pilar
The potential of using image-guided photodynamic therapy (ig-PDT) for cancer, especially with highly biocompatible fluorescent agents free of heavy atoms, is well recognized. This is due to key advantages related to minimizing adverse side effects associated with standard cancer chemotherapy. However, this theragnostic approach is strongly limited by the lack of synthetically-accessible and easily-modulable chemical scaffolds, enabling the rapid design and construction of advanced agents for clinical ig-PDT. In fact, there are still very few ig-PDT agents clinically approved. Herein we report a readily accessible, easy-tunable and highly fluorescent all-organic small photosensitizer, as a model design for accelerating the development and translation of advanced ig-PDT agents for cancer. This scaffold is based on BODIPY, which assures high fluorescence, accessibility, and ease of performance adaptation by workable chemistry. The optimal PDT performance of this BODIPY dye, tested in highly resistant pancreatic cancer cells, despite its high fluorescent behavior, maintained even after fixation and cancer cell death, is based on its selective accumulation in mitochondria. This induces apoptosis upon illumination, as evidenced by proteomic studies and flow cytometry. All these characteristics make the reported BODIPY-based fluorescent photosensitizer a valuable model for the rapid development of ig-PDT agents for clinical use.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Heavy-atom-free BODIPY-based photodynamic therapy agents activated at long wavelengths

  • Soler-Beatty, Jennifer
  • Avellanal-Zaballa, Edurne
  • Durán-Sampedro, Gonzalo
  • Agarrabeitia, Antonia R.
  • Bañuelos, Jorge
  • Ortiz, María J.
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Photodynamic therapy (PDT) is an emerging clinical tool that uses light as an agent unleashing cytotoxic activity for treating cancer and other diseases, including those showing drug resistance. One of the main areas of research to fully implement PDT as a real alternative to chemo or radiotherapy is the development of improved photosensitizers (PSs). This work aims to contribute to the design of novel PSs able to generate reactive oxygen species (ROS) upon activation with light within the biological window (deep red or near-infrared region) while being non-toxic under dark conditions (heavy-atom-free). For this, we have chosen BODIPY-based covalent dimers directly linked through their 3-position as model structures. This molecular scaffold has been previously tested as a fluorescent probe to stain cells, but not as a PS for ROS generation under red illumination. Using readily available synthetic protocols, we have changed the steric hindrance around the linkage and added functional groups suited to enhance targetable biorecognition and solubility in physiological media. The spectroscopic characterization confirms that these dimers are photoactivated in a spectral window approaching 700 nm and display noticeable fluorescence signals beyond this wavelength, together with a notable generation of singlet oxygen. Encouraged by these photophysical signatures, we conducted in vitro trials in cancer cells. These assays ratify the ability of most of the herein reported dimers to sensitize ROS and induce cell death upon long-wavelength illumination., The authors acknowledge grants PID2020-114755GB-C32 and -C33, and PID2021-128141OB-C22 funded by the Spanish MCIN/AEI/10.13039/501100011033, and grant IT1639-22 funded by the Basque Government.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Covalent organic frameworks as nanocarriers of tailored BODIPY for phototheragnostic applications

  • Jimenez-Duro, Miguel
  • Soler-Beatty, Jennifer
  • Martinez-Fernandez, Marcos
  • Avellanal-Zaballa, Edurne
  • Martinez, Jose I.
  • Ortiz, Maria J.
  • Duran-Sampedro, Gonzalo
  • Banuelos, Jorge
  • Segura, Jose L.
  • Soriano-Teruel, Paula
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Grafting fluorophores and photosensitizers onto nanocarriers is recognized as an effective strategy for fluorescent bioimaging and photodynamic therapy. This approach enhances targeted drug delivery to tumor sites, while improving the biocompatibility and stability of poorly water-soluble bioprobes, thereby reducing side effects. Among the available organic dyes and nanoparticles, BODIPY and COF stand out as a compatible pair for this purpose. To leverage the COF-BODIPY scaffold as a photoactive platform for biomedical applications, we have optimized their integration. To this aim, first, BODIPY units were functionalized to enable strong binding to specific sites of the COF via click chemistry, positioning the BODIPY within the pores of the COF. Following this approach, BODIPY derivatives photoactive across different spectral regions (from the green to the red window) were straightforwardly grafted onto the COF. The structural and photophysical properties of these nanomaterials were thoroughly characterized. Notably, the COF bearing styrylated and iodinated BODIPY was especially appealing due to its dual photonic performance, enabling both singlet oxygen generation and red fluorescence under long-wavelength excitation. Upon its cellular uptake by human melanoma cells, this dyed nanoparticle selectively stained lysosomes, and at the same time triggered a cytotoxic response to induce cell death under illumination with red light, thus being a suitable candidate for theragnostic purposes., This research was supported by projects: TED2021-129886B-C43 granted by MCIN/AEI/10.13039/501100011033 and the European Union NextGeneration EU/PRTR; PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund - A way of doing Europe; PID2022-138908NB-C33 and PID2024-157648-NB-C22 granted by MICIU/AEI/10.13039/501100011033 and FEDER, UE. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) and Gobierno Vasco (IT1639-22). The work was supported by CIBER -Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. J. L. S. acknowledges the MICIIN for the REDES project "RED2022-134503-T". P. M. S-T. is grateful to the Generalitat Valenciana for a postdoctoral Investigo contract (INVEST/2023/443). J. I. M. acknowledges funding from Spanish MCIN (Grants PID2023-149077OB-C31, TED2021-12941A-I00 and PLEC2021-007906 funded by MCIN/AEI/10.13039/501100011033 and by the "European Union NextGenerationEU/PRTR"), and Comunidad de Madrid (Grant TEC-2024/TEC-459). The Severo Ochoa Centres of Excellence program through Grant CEX2024-001445-S is also acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Solar Gas-Phase CO2 Hydrogenation by Multifunctional UiO-66 Photocatalysts

  • Rueda-Navarro, Celia Maria|||0000-0002-9569-7722
  • Melillo, Arianna
  • Vayá Pérez, Ignacio|||0000-0003-1682-9342
  • Navalón Oltra, Sergio|||0000-0001-8423-0759
  • Abou Khalil, Zahraa
  • Ferrer, Belen
  • Montero, Raul
  • Longarte, Asier
  • Daturi, Marco
  • El-Roz, Mohamad
  • Martínez-Martínez, Virginia
  • Baldovi, Herme G.
[EN] Solar-assisted CO2 conversion into fuels and chemical products involves a range of technologies aimed at driving industrial decarbonization methods. In this work, we report on the development of a series of multifunctional metal-organic frameworks (MOFs) based on nitro- or amino-functionalized UiO-66(M) (M: Zr or Zr/Ti) supported RuOx NPs as photocatalysts, having different energy band level diagrams, for CO2 hydrogenation under simulated concentrated sunlight irradiation. RuOx(1 wt %; 2.2 +/- 0.9 nm)@UiO-66(Zr/Ti)-NO2 was found to be a reusable photocatalyst, to be selective for CO2 methanation (5.03 mmol g(-1) after 22 h;, apparent quantum yield at 350, 400, and 600 nm of 1.67, 0.25, and 0.01%, respectively), and to show about 3-6 times activity compared with previous investigations. The photocatalysts were characterized by advanced spectroscopic techniques like femto- and nanosecond transient absorption, spin electron resonance, and photoluminescence spectroscopies together with (photo)electrochemical measurements. The photocatalytic CO2 methanation mechanism was assessed by operando FTIR spectroscopy. The results indicate that the most active photocatalyst operates under a dual photochemical and photothermal mechanism. This investigation shows the potential of multifunctional MOFs as photocatalysts for solar-driven CO2 recycling., C.M.R.N. thanks the support of PRE2019-089877 funded by MICIU/AEI/10.13039/501100011033. I.V. thanks the support of grant PID2020-115010RB-I00 funded by MICIU/AEI/10.13039/501100011033. A.L. thanks the support from the MICIU through grant PID2021-127918NB-I00. V.M.M. thanks financial support of grants PID2020-114347RB-C32 funded by MICIU/AEI/10.13039/501100011033 as well as Vasco-Eusko Jaurlaritza (project IT1639-22) and by ERDF "A way of making Europe". The METHASOL project receives funding from the European Union Horizon 2020 research and innovation programme under Grant Agreement N degrees 10102264. Funding for open access charge: CRUE-Universitat Politecnica de Valencia. S.N. thanks the support of grant PID2021-123856OBI00 funded by MICIU/AEI/10.13039/501100011033 and by ERDF "A way of making Europe".
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Development of Geometry-Controlled All-Orthogonal BODIPY Trimers for Photodynamic Therapy and Phototheragnosis

  • Prieto-Castañeda, Alejandro
  • García-Garrido, Fernando
  • Díaz-Norambuena, Carolina
  • Escriche-Navarro, Blanca
  • Bañuelos, Jorge
  • Rebollar, Esther
  • García-Moreno, Inmaculada
  • de la Moya, Santiago
  • Agarrabeitia, Antonia R.
  • Ortiz, María J.
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] We have established an easy synthetic protocol for selectively developing all-orthogonal BODIPY trimers with unprece-dented geometries on the basis of selecting methyl oxidation versus electrophilic formylation of key dimeric precursors. Photophysical characterization together with biological assays unraveled the most suitable BODIPY-BODIPY geometrical arrangements within the trimer, forcing them to serve as molecular platforms for the development of new, advanced heavy-atom-free photosensitizers for photodynamic therapy and phototheragnosis., The authors acknowledge Spanish MICINN (PID2020-11455GB-C31, -C32, and -C33 and RTI2018-100910-BC41), Spanish Instituto de Salud Carlos III (IFI19/00026), Gobierno Vasco (IT1639-22), and Generalitat Valenciana (PROMETEO 2018/024) for financial support. A.P.-C. thanks Comunidad de Madrid for a research contract. C.D.-N. thanks MICINN for a FPI contract. B.E.-N. thanks the IFI19/00026 project, which is co-funded by the European Union, for a research contract.